Skip to main content
OpenTrials

Clinical trial condition

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Explore clinical trials studying Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) trial results

NCT06073587

Conditions
Amyloidosis, Cardiomyopathies, Cardiovascular Diseases, +5 more
Locations
  • Columbia University Irving Medical Center New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Cleveland Clinic Main Campus Cleveland, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
Conditions
Amyloidosis, Cardiomyopathies, Cardiovascular Diseases, +5 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Azienda Ospedaliero - Universitaria Careggi Florence, Italy
  • Azienda Ospedale Università di Padova Padova, Italy